Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paroxysmal nocturnal hemoglobinuria. A complement-mediated disease.

J A Halperin1, A Nicholson-Weller

  • 1Department of Physiology and Biophysics, Harvard Medical School, Boston, Mass.

Complement and Inflammation
|January 1, 1989
PubMed
Summary

Paroxysmal nocturnal hemoglobinuria (PNH) is a hemolytic disease where blood cells lack protective proteins, leading to complement system attack. This review covers PNH

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The future of compounding: an industry perspective.

International journal of pharmaceutical compounding·2013
Same author

Glycated-CD59 antigen: exploration of synthetic approaches.

Advances in experimental medicine and biology·2009
Same author

Antibody CR1-2B11 recognizes a non-polymorphic epitope of human CR1 (CD35).

Clinical and experimental immunology·2007
Same author

Analysis of the promoters and 5'-UTR of mouse Cd59 genes, and of their functional activity in erythrocytes.

Genes and immunity·2006
Same author

C5L2 receptor is not involved in C3a / C3a-desArg-mediated enhancement of bone marrow hematopoietic cell migration to CXCL12.

Leukemia·2005
Same author

A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1).

Clinical and experimental immunology·2005

Area of Science:

  • Hematology
  • Immunology
  • Molecular Biology

Background:

  • Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hemolytic anemia.
  • PNH erythrocytes exhibit increased susceptibility to complement-mediated lysis.
  • Deficiency of specific complement regulatory proteins (decay-accelerating factor, C8-binding protein) on PNH cells is a key characteristic.

Purpose of the Study:

  • To review the clinical, biological, and molecular aspects of PNH.
  • To discuss current diagnostic methods for PNH.
  • To propose novel diagnostic approaches using indirect immunofluorescence.

Main Methods:

  • Literature review of PNH pathogenesis, clinical manifestations, and molecular basis.
  • Analysis of established diagnostic tests for PNH.
  • Evaluation of indirect immunofluorescence assays for PNH diagnosis.

Main Results:

  • PNH cells lack glycosylphosphatidylinositol (GPI)-anchored proteins, including complement regulators.
  • This deficiency renders erythrocytes vulnerable to complement attack.
  • Current diagnostic tests identify PNH, but new methods offer potential improvements.

Conclusions:

  • PNH is characterized by a deficiency in GPI-anchored proteins, leading to complement dysregulation.
  • Understanding PNH pathophysiology is crucial for diagnosis and management.
  • Indirect immunofluorescence assays represent a promising advancement in PNH diagnostics.

Related Experiment Videos